Thanks for info. I see Abacus even has a subsidiary in Israel. Should be great for conducting any clinical trials. I am doing DD now, and am pleasantly surprised by the news today.
Abacus has a nice balance sheet which shows $28,239,000 in cash and cash equivalents, $43,583,000 in assets, and only $7,285,000 in liabilities for last Q report: